Search

everythinglearnresearchcommunity

for

Search:↓

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Cetuximab can cause excessive eyelash growth.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Upadacitinib may effectively treat resistant lichen planopilaris.

Lasers can help reduce skin side effects from cancer treatment.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Combining pemetrexed with platinum drugs improves treatment outcomes and quality of life for elderly patients with advanced lung adenocarcinoma.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Erlotinib can cause hair loss as a side effect.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Upadacitinib effectively treats psoriasis and lichen planus together.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.